Cargando…
Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial
AIM: To investigate whether an intensive lifestyle intervention induces partial or complete type 2 diabetes (T2D) remission. MATERIALS AND METHODS: In a secondary analysis of a randomized, assessor‐blinded, single‐centre trial, people with non‐insulin‐dependent T2D (duration <10 years), were rand...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772176/ https://www.ncbi.nlm.nih.gov/pubmed/31168922 http://dx.doi.org/10.1111/dom.13802 |
_version_ | 1783455854429732864 |
---|---|
author | Ried‐Larsen, Mathias Johansen, Mette Y. MacDonald, Christopher S. Hansen, Katrine B. Christensen, Robin Wedell‐Neergaard, Anne‐Sophie Pilmark, Nanna Skytt Langberg, Henning Vaag, Allan A. Pedersen, Bente K. Karstoft, Kristian |
author_facet | Ried‐Larsen, Mathias Johansen, Mette Y. MacDonald, Christopher S. Hansen, Katrine B. Christensen, Robin Wedell‐Neergaard, Anne‐Sophie Pilmark, Nanna Skytt Langberg, Henning Vaag, Allan A. Pedersen, Bente K. Karstoft, Kristian |
author_sort | Ried‐Larsen, Mathias |
collection | PubMed |
description | AIM: To investigate whether an intensive lifestyle intervention induces partial or complete type 2 diabetes (T2D) remission. MATERIALS AND METHODS: In a secondary analysis of a randomized, assessor‐blinded, single‐centre trial, people with non‐insulin‐dependent T2D (duration <10 years), were randomly assigned (2:1, stratified by sex, from April 2015 to August 2016) to a lifestyle intervention group (n = 64) or a standard care group (n = 34). The primary outcome was partial or complete T2D remission, defined as non‐diabetic glycaemia with no glucose‐lowering medication at the outcome assessments at both 12 and 24 months from baseline. All participants received standard care, with standardized, blinded, target‐driven medical therapy during the initial 12 months. The lifestyle intervention included 5‐ to 6‐weekly aerobic and combined aerobic and strength training sessions (30‐60 minutes) and individual dietary plans aiming for body mass index ≤25 kg/m(2). No intervention was provided during the 12‐month follow‐up period. RESULTS: Of the 98 randomized participants, 93 completed follow‐up (mean [SD] age 54.6 [8.9] years; 46 women [43%], mean [SD] baseline glycated haemoglobin 49.3 [9.3] mmol/mol). At follow‐up, 23% of participants (n = 14) in the intervention and 7% (n = 2) in the standard care group met the criteria for any T2D remission (odds ratio [OR] 4.4, 95% confidence interval [CI] 0.8‐21.4]; P = 0.08). Assuming participants lost to follow‐up (n = 5) had relapsed, the OR for T2D remission was 4.4 (95% CI 1.0–19.8; P = 0.048). CONCLUSIONS: The statistically nonsignificant threefold increased remission rate of T2D in the lifestyle intervention group calls for further large‐scale studies to understand how to implement sustainable lifestyle interventions among people with T2D. |
format | Online Article Text |
id | pubmed-6772176 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-67721762019-10-07 Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial Ried‐Larsen, Mathias Johansen, Mette Y. MacDonald, Christopher S. Hansen, Katrine B. Christensen, Robin Wedell‐Neergaard, Anne‐Sophie Pilmark, Nanna Skytt Langberg, Henning Vaag, Allan A. Pedersen, Bente K. Karstoft, Kristian Diabetes Obes Metab Original Articles AIM: To investigate whether an intensive lifestyle intervention induces partial or complete type 2 diabetes (T2D) remission. MATERIALS AND METHODS: In a secondary analysis of a randomized, assessor‐blinded, single‐centre trial, people with non‐insulin‐dependent T2D (duration <10 years), were randomly assigned (2:1, stratified by sex, from April 2015 to August 2016) to a lifestyle intervention group (n = 64) or a standard care group (n = 34). The primary outcome was partial or complete T2D remission, defined as non‐diabetic glycaemia with no glucose‐lowering medication at the outcome assessments at both 12 and 24 months from baseline. All participants received standard care, with standardized, blinded, target‐driven medical therapy during the initial 12 months. The lifestyle intervention included 5‐ to 6‐weekly aerobic and combined aerobic and strength training sessions (30‐60 minutes) and individual dietary plans aiming for body mass index ≤25 kg/m(2). No intervention was provided during the 12‐month follow‐up period. RESULTS: Of the 98 randomized participants, 93 completed follow‐up (mean [SD] age 54.6 [8.9] years; 46 women [43%], mean [SD] baseline glycated haemoglobin 49.3 [9.3] mmol/mol). At follow‐up, 23% of participants (n = 14) in the intervention and 7% (n = 2) in the standard care group met the criteria for any T2D remission (odds ratio [OR] 4.4, 95% confidence interval [CI] 0.8‐21.4]; P = 0.08). Assuming participants lost to follow‐up (n = 5) had relapsed, the OR for T2D remission was 4.4 (95% CI 1.0–19.8; P = 0.048). CONCLUSIONS: The statistically nonsignificant threefold increased remission rate of T2D in the lifestyle intervention group calls for further large‐scale studies to understand how to implement sustainable lifestyle interventions among people with T2D. Blackwell Publishing Ltd 2019-06-30 2019-10 /pmc/articles/PMC6772176/ /pubmed/31168922 http://dx.doi.org/10.1111/dom.13802 Text en © 2019 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Ried‐Larsen, Mathias Johansen, Mette Y. MacDonald, Christopher S. Hansen, Katrine B. Christensen, Robin Wedell‐Neergaard, Anne‐Sophie Pilmark, Nanna Skytt Langberg, Henning Vaag, Allan A. Pedersen, Bente K. Karstoft, Kristian Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial |
title | Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial |
title_full | Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial |
title_fullStr | Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial |
title_full_unstemmed | Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial |
title_short | Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial |
title_sort | type 2 diabetes remission 1 year after an intensive lifestyle intervention: a secondary analysis of a randomized clinical trial |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772176/ https://www.ncbi.nlm.nih.gov/pubmed/31168922 http://dx.doi.org/10.1111/dom.13802 |
work_keys_str_mv | AT riedlarsenmathias type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT johansenmettey type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT macdonaldchristophers type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT hansenkatrineb type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT christensenrobin type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT wedellneergaardannesophie type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT pilmarknannaskytt type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT langberghenning type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT vaagallana type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT pedersenbentek type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial AT karstoftkristian type2diabetesremission1yearafteranintensivelifestyleinterventionasecondaryanalysisofarandomizedclinicaltrial |